265 related articles for article (PubMed ID: 35241534)
21. Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports.
Schifano N; Chiappini S; Castiglione F; Salonia A; Schifano F
Low Urin Tract Symptoms; 2021 Apr; 13(2):230-237. PubMed ID: 33037767
[TBL] [Abstract][Full Text] [Related]
22. The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study.
Schutte T; van Eekeren R; Richir M; van Staveren J; van Puijenbroek E; Tichelaar J; van Agtmael M
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):17-26. PubMed ID: 29063137
[TBL] [Abstract][Full Text] [Related]
23. Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland.
O'Callaghan J; Griffin BT; Morris JM; Bermingham M
BioDrugs; 2018 Jun; 32(3):267-280. PubMed ID: 29721705
[TBL] [Abstract][Full Text] [Related]
24. The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions.
Clark RC; Maxwell SR; Kerr S; Cuthbert M; Buchanan D; Steinke D; Webb DJ; Bateman ND
Drug Saf; 2007; 30(4):357-66. PubMed ID: 17408312
[TBL] [Abstract][Full Text] [Related]
25. Clarification of adverse drug reactions by a pharmacovigilance team results in increased antibiotic re-prescribing at a freestanding United States children's hospital.
Feldman K; Suppes SL; Goldman JL
PLoS One; 2024; 19(1):e0295410. PubMed ID: 38215178
[TBL] [Abstract][Full Text] [Related]
26. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
[TBL] [Abstract][Full Text] [Related]
27. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
Inácio P; Airaksinen M; Cavaco A
Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
[TBL] [Abstract][Full Text] [Related]
28. An analysis of the trends, characteristics, scope, and performance of the Zimbabwean pharmacovigilance reporting scheme.
Masuka JT; Khoza S
Pharmacol Res Perspect; 2020 Oct; 8(5):e00657. PubMed ID: 32930524
[TBL] [Abstract][Full Text] [Related]
29. [Under-reporting of adverse drug reactions, a problem that also involves medicines subject to additional monitoring. Preliminary data from a single-center experience on novel oral anticoagulants].
Patrignani A; Palmieri G; Ciampani N; Moretti V; Mariani A; Racca L
G Ital Cardiol (Rome); 2018 Jan; 19(1):54-61. PubMed ID: 29451510
[TBL] [Abstract][Full Text] [Related]
30. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
Adenuga BA; Kibuule D; Rennie TW
Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
[TBL] [Abstract][Full Text] [Related]
31. Bulgarian Experience with Adverse Drug Reaction Reports from Patients and Consumers - Retrospective Data-base Study.
Getova VI; Georgiev SR; Stoimenova AH; Petkova-Georgieva ES
Folia Med (Plovdiv); 2018 Sep; 60(3):447-453. PubMed ID: 30355838
[TBL] [Abstract][Full Text] [Related]
32. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
Zhou Z; Hultgren KE
JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
[TBL] [Abstract][Full Text] [Related]
33. Adverse drug reaction reporting: how can drug consumption information add to analyses using spontaneous reports?
Svendsen K; Halvorsen KH; Vorren S; Samdal H; Garcia B
Eur J Clin Pharmacol; 2018 Apr; 74(4):497-504. PubMed ID: 29255992
[TBL] [Abstract][Full Text] [Related]
34. Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions.
Li R; Curtis K; Zaidi STR; Van C; Thomson A; Castelino R
Expert Opin Drug Saf; 2021 Oct; 20(10):1267-1274. PubMed ID: 34077311
[No Abstract] [Full Text] [Related]
35. What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?
Januskiene J; Segec A; Slattery J; Genov G; Plueschke K; Kurz X; Arlett P
Pharmacoepidemiol Drug Saf; 2021 Mar; 30(3):334-341. PubMed ID: 33099846
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital.
Pimpalkhute SA; Jaiswal KM; Sontakke SD; Bajait CS; Gaikwad A
Indian J Med Sci; 2012; 66(3-4):55-61. PubMed ID: 23603621
[TBL] [Abstract][Full Text] [Related]
37. Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.
Patadia VK; Coloma P; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Fornari C; Pedersen L; van der Lei J; Sturkenboom M; Trifirò G;
Expert Rev Clin Pharmacol; 2015 Jan; 8(1):95-102. PubMed ID: 25487079
[TBL] [Abstract][Full Text] [Related]
38. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.
Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B
Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811
[TBL] [Abstract][Full Text] [Related]
39. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
[TBL] [Abstract][Full Text] [Related]
40. Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases.
Machado-Alba JE; Londoño-Builes MJ; Echeverri-Cataño LF; Ochoa-Orozco SA
Biomedica; 2016 Mar; 36(1):59-66. PubMed ID: 27622439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
